HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

5th Edition of

International Ophthalmology Conference

Translational and Experimental Ophthalmology

Translational and Experimental Ophthalmology

Translational and experimental ophthalmology bridges the gap between laboratory research and clinical practice, turning scientific discoveries into practical treatments. By focusing on innovative research, this field seeks to translate basic science into real-world applications, offering new treatments for ocular diseases such as retinal degeneration, corneal disorders, and optic neuropathies. Advances in gene therapy, stem cell research, and novel drug delivery systems are among the key areas driving progress. This research is crucial for improving treatments for conditions like age-related macular degeneration, where conventional therapies often fall short. Translational efforts are not only focused on developing new therapies but also on optimizing current treatment protocols to improve patient outcomes. The ultimate goal is to improve patient care by integrating cutting-edge scientific findings into clinical practice, offering hope for individuals with conditions that were once considered untreatable.

Committee Members

Speaker at IOC 2027 - Anna Maria Bassi

Anna Maria Bassi

University of Genoa, Italy
Speaker at IOC 2027 - Magali Taiel

Magali Taiel

GenSight Biologics, France
Speaker at IOC 2027 - Pierdomenico D Andrea

Pierdomenico D Andrea

University “G. D’Annunzio, Italy

IOC 2027 Speakers

Speaker at IOC 2027 - Abdullah Shakeel

Abdullah Shakeel

Princess Alexandra Hospital NHS Trust, United Kingdom
Speaker at IOC 2027 - Chaitra MC

Chaitra MC

Sri Devaraj Urs Medical College, India
Speaker at IOC 2027 - Hyungju Park

Hyungju Park

Gangnam Tokyo Eye Clinic, Korea, Republic of
Speaker at IOC 2027 - Shadrokh Nabili

Shadrokh Nabili

University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom

Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp